2022-03-022023-03-012023-03-01false09448220SHARON MASON NURSE CONSULTANCY LIMITED2023-09-1386900iso4217:GBPxbrli:pure094482202022-03-02094482202023-03-01094482202022-03-022023-03-01094482202021-03-02094482202022-03-01094482202021-03-022022-03-0109448220bus:SmallEntities2022-03-022023-03-0109448220bus:AuditExempt-NoAccountantsReport2022-03-022023-03-0109448220bus:AbridgedAccounts2022-03-022023-03-0109448220bus:PrivateLimitedCompanyLtd2022-03-022023-03-0109448220core:WithinOneYear2023-03-0109448220core:AfterOneYear2023-03-0109448220core:WithinOneYear2022-03-0109448220core:AfterOneYear2022-03-0109448220core:ShareCapital2023-03-0109448220core:SharePremium2023-03-0109448220core:RevaluationReserve2023-03-0109448220core:OtherReservesSubtotal2023-03-0109448220core:RetainedEarningsAccumulatedLosses2023-03-0109448220core:ShareCapital2022-03-0109448220core:SharePremium2022-03-0109448220core:RevaluationReserve2022-03-0109448220core:OtherReservesSubtotal2022-03-0109448220core:RetainedEarningsAccumulatedLosses2022-03-0109448220core:LandBuildings2023-03-0109448220core:PlantMachinery2023-03-0109448220core:Vehicles2023-03-0109448220core:FurnitureFittings2023-03-0109448220core:OfficeEquipment2023-03-0109448220core:NetGoodwill2023-03-0109448220core:IntangibleAssetsOtherThanGoodwill2023-03-0109448220core:ListedExchangeTraded2023-03-0109448220core:UnlistedNon-exchangeTraded2023-03-0109448220core:LandBuildings2022-03-0109448220core:PlantMachinery2022-03-0109448220core:Vehicles2022-03-0109448220core:FurnitureFittings2022-03-0109448220core:OfficeEquipment2022-03-0109448220core:NetGoodwill2022-03-0109448220core:IntangibleAssetsOtherThanGoodwill2022-03-0109448220core:ListedExchangeTraded2022-03-0109448220core:UnlistedNon-exchangeTraded2022-03-0109448220core:LandBuildings2022-03-022023-03-0109448220core:PlantMachinery2022-03-022023-03-0109448220core:Vehicles2022-03-022023-03-0109448220core:FurnitureFittings2022-03-022023-03-0109448220core:OfficeEquipment2022-03-022023-03-0109448220core:NetGoodwill2022-03-022023-03-0109448220core:IntangibleAssetsOtherThanGoodwill2022-03-022023-03-0109448220core:ListedExchangeTraded2022-03-022023-03-0109448220core:UnlistedNon-exchangeTraded2022-03-022023-03-0109448220core:MoreThanFiveYears2022-03-022023-03-0109448220core:Non-currentFinancialInstruments2023-03-0109448220core:Non-currentFinancialInstruments2022-03-0109448220dpl:CostSales2022-03-022023-03-0109448220dpl:DistributionCosts2022-03-022023-03-0109448220dpl:AdministrativeExpenses2022-03-022023-03-0109448220core:LandBuildings2022-03-022023-03-0109448220core:PlantMachinery2022-03-022023-03-0109448220core:Vehicles2022-03-022023-03-0109448220core:FurnitureFittings2022-03-022023-03-0109448220core:OfficeEquipment2022-03-022023-03-0109448220core:NetGoodwill2022-03-022023-03-0109448220core:IntangibleAssetsOtherThanGoodwill2022-03-022023-03-0109448220dpl:GroupUndertakings2022-03-022023-03-0109448220dpl:ParticipatingInterests2022-03-022023-03-0109448220dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-022023-03-0109448220core:ListedExchangeTraded2022-03-022023-03-0109448220dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-022023-03-0109448220core:UnlistedNon-exchangeTraded2022-03-022023-03-0109448220dpl:CostSales2021-03-022022-03-0109448220dpl:DistributionCosts2021-03-022022-03-0109448220dpl:AdministrativeExpenses2021-03-022022-03-0109448220core:LandBuildings2021-03-022022-03-0109448220core:PlantMachinery2021-03-022022-03-0109448220core:Vehicles2021-03-022022-03-0109448220core:FurnitureFittings2021-03-022022-03-0109448220core:OfficeEquipment2021-03-022022-03-0109448220core:NetGoodwill2021-03-022022-03-0109448220core:IntangibleAssetsOtherThanGoodwill2021-03-022022-03-0109448220dpl:GroupUndertakings2021-03-022022-03-0109448220dpl:ParticipatingInterests2021-03-022022-03-0109448220dpl:GroupUndertakingscore:ListedExchangeTraded2021-03-022022-03-0109448220core:ListedExchangeTraded2021-03-022022-03-0109448220dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-03-022022-03-0109448220core:UnlistedNon-exchangeTraded2021-03-022022-03-0109448220core:NetGoodwill2023-03-0109448220core:IntangibleAssetsOtherThanGoodwill2023-03-0109448220core:LandBuildings2023-03-0109448220core:PlantMachinery2023-03-0109448220core:Vehicles2023-03-0109448220core:FurnitureFittings2023-03-0109448220core:OfficeEquipment2023-03-0109448220core:AfterOneYear2023-03-0109448220core:WithinOneYear2023-03-0109448220core:ListedExchangeTraded2023-03-0109448220core:UnlistedNon-exchangeTraded2023-03-0109448220core:ShareCapital2023-03-0109448220core:SharePremium2023-03-0109448220core:RevaluationReserve2023-03-0109448220core:OtherReservesSubtotal2023-03-0109448220core:RetainedEarningsAccumulatedLosses2023-03-0109448220core:NetGoodwill2022-03-0109448220core:IntangibleAssetsOtherThanGoodwill2022-03-0109448220core:LandBuildings2022-03-0109448220core:PlantMachinery2022-03-0109448220core:Vehicles2022-03-0109448220core:FurnitureFittings2022-03-0109448220core:OfficeEquipment2022-03-0109448220core:AfterOneYear2022-03-0109448220core:WithinOneYear2022-03-0109448220core:ListedExchangeTraded2022-03-0109448220core:UnlistedNon-exchangeTraded2022-03-0109448220core:ShareCapital2022-03-0109448220core:SharePremium2022-03-0109448220core:RevaluationReserve2022-03-0109448220core:OtherReservesSubtotal2022-03-0109448220core:RetainedEarningsAccumulatedLosses2022-03-0109448220core:NetGoodwill2021-03-0209448220core:IntangibleAssetsOtherThanGoodwill2021-03-0209448220core:LandBuildings2021-03-0209448220core:PlantMachinery2021-03-0209448220core:Vehicles2021-03-0209448220core:FurnitureFittings2021-03-0209448220core:OfficeEquipment2021-03-0209448220core:AfterOneYear2021-03-0209448220core:WithinOneYear2021-03-0209448220core:ListedExchangeTraded2021-03-0209448220core:UnlistedNon-exchangeTraded2021-03-0209448220core:ShareCapital2021-03-0209448220core:SharePremium2021-03-0209448220core:RevaluationReserve2021-03-0209448220core:OtherReservesSubtotal2021-03-0209448220core:RetainedEarningsAccumulatedLosses2021-03-0209448220core:AfterOneYear2022-03-022023-03-0109448220core:WithinOneYear2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:CostValuation2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-022023-03-0109448220core:Non-currentFinancialInstrumentscore:CostValuation2023-03-0109448220core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-0109448220core:Non-currentFinancialInstrumentscore:CostValuation2022-03-0109448220core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-0109448220core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-0109448220bus:Director12022-03-022023-03-01

SHARON MASON NURSE CONSULTANCY LIMITED

Registered Number
09448220
(England and Wales)

Unaudited Financial Statements for the Year ended
1 March 2023

SHARON MASON NURSE CONSULTANCY LIMITED
Company Information
for the year from 2 March 2022 to 1 March 2023

Director

MASON, Sharon Mary

Registered Address

Lumbview Accounts, Grosvenor House Downcast Way
Swinton
Manchester
M27 8UW

Registered Number

09448220 (England and Wales)
SHARON MASON NURSE CONSULTANCY LIMITED
Balance Sheet as at
1 March 2023

Notes

2023

2022

£

£

£

£

Current assets
Cash at bank and on hand1112
1112
Creditors amounts falling due within one year(13,913)(13,800)
Net current assets (liabilities)(13,902)(13,788)
Total assets less current liabilities(13,902)(13,788)
Net assets(13,902)(13,788)
Capital and reserves
Called up share capital11
Profit and loss account(13,903)(13,789)
Shareholders' funds(13,902)(13,788)
The financial statements were approved and authorised for issue by the Director on 13 September 2023, and are signed on its behalf by:
MASON, Sharon Mary
Director
Registered Company No. 09448220
SHARON MASON NURSE CONSULTANCY LIMITED
Notes to the Financial Statements
for the year ended 1 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
4.Employee information

20232022
Average number of employees during the year00